Industry News
Aldridge quits Peplin
Peplin appoints new CEO and president/CMO [ + ]
Patent no loss of MatrixView
MatrixView awarded European patent for data management technology [ + ]
$3 million for Chagas research
Murdoch University and Epichem get $3 million Chagas research boost [ + ]
Genentech rejects Roche bid
US biotech Genentech rejects $43.7 billion takeover deal [ + ]
Acrux-Organon partnership dropped
Schering-Plough cancels two projects with Acrux [ + ]
Life's Full Court appeal accepted
Life's legal battle with Bell IXL will continue, after the Full Court ordered a retrial. [ + ]
Stalling PTKs in their tracks
An enzyme called TCPTP keeps a tight rein on damaged DNA [ + ]
Acrux heads to the Finnish
Acrux signs exclusive manufacturing partner for Testosterone MD-Lotion [ + ]
Circadian owns Vegenics
Circadian finalises Vegenics purchase [ + ]
Biotron expands HCV trial
Biotron adds Brisbane site for hep C clinical trial [ + ]
Next trial for Starpharma
Starpharma studies VivaGel duration [ + ]
Colman wins Victoria Prize
WEHI's Peter Colman wins Victoria's top science prize [ + ]
CSL profit up 30pc, to outlay $3.5b for Talecris
CSL reports massive earnings, agrees to buy US plasma business Talecris [ + ]
Clean air for Pharmaxis
Pharmaxis concludes dose study of Bronchitol in cystic fibrosis patients [ + ]
Patched and the cell of origin battle
Researchers answer brain tumour 'cell of origin' question [ + ]
